Solicitation of Nominations for Appointment to the Advisory Committee on Immunization Practices, 58378-58379 [2024-15792]

Download as PDF khammond on DSKJM1Z7X2PROD with NOTICES 58378 Federal Register / Vol. 89, No. 138 / Thursday, July 18, 2024 / Notices NIOSH–232, by either of the methods listed below. CDC does not accept comments by email. • Federal eRulemaking Portal: https://www.regulations.gov. Follow the instructions for submitting comments. • Mail: Ms. Sherri Diana, NIOSH Docket Office, National Institute for Occupational Safety and Health, 1090 Tusculum Avenue, Mailstop C–34, Cincinnati, Ohio 45226. Attn: Docket No. CDC–2024–0055; NIOSH–232. Instructions: All submissions received must include the Agency name and docket number. Docket number CDC– 2024–0055; NIOSH–232 will close August 15, 2024. FOR FURTHER INFORMATION CONTACT: Kandyce Reeves, M.P.H., Designated Federal Officer, Board of Scientific Counselors, National Institute for Occupational Safety and Health, National Firefighter Registry Subcommittee, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop V24–4, Atlanta, Georgia 30329–4027. Telephone: (404) 498–1650; Email: KReeves3@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The Secretary of Health and Human Services, the Assistant Secretary for Health, and by delegation, the Director, Centers for Disease Control and Prevention (CDC), are authorized under Sections 301 and 308 of the Public Health Service Act to conduct directly, or by grants or contracts, research, experiments, and demonstrations relating to occupational safety and health and to mine health. The Board of Scientific Counselors, National Institute for Occupational Safety and Health (BSC, NIOSH) provides advice to the NIOSH Director on NIOSH research and prevention programs. The Board also provides guidance on the Institute’s research activities related to developing and evaluating hypotheses, systematically documenting findings, and disseminating results. In addition, the Board evaluates the degree to which the activities of NIOSH: (1) conform to those standards of scientific excellence appropriate for Federal scientific institutions in accomplishing objectives in occupational safety and health; (2) address currently relevant needs in the fields of occupational safety and health either alone or in conjunction with other known activities inside and outside of NIOSH; and (3) produce their intended results in addressing important research questions in occupational safety and health, both in terms of applicability of the research findings and dissemination of the findings. VerDate Sep<11>2014 16:47 Jul 17, 2024 Jkt 262001 Purpose: The BSC, NIOSH National Firefighter Registry Subcommittee provides scientific expertise to the Board that assists the BSC, NIOSH in advising the NIOSH Director about the Institute’s efforts to establish and operate the National Firefighter Registry for Cancer. Specifically, the Subcommittee advises the Board on the following issues pertaining to the ‘‘required strategy’’ as mandated by the Firefighter Cancer Registry Act of 2018 (the Act): (1) increase awareness of the National Firefighter Registry for Cancer and encourage participation among all groups of firefighters; (2) consider data collection needs; (3) consider data storage and electronic access of health information; and (4) in consultation with subject matter experts, develop a method for estimating the number and type of fire incidents attended by a firefighter. Additional responsibilities of the Subcommittee are to provide guidance to the Board regarding the inclusion and maintenance of data on firefighters as required by the Act. Matters to be Considered: The agenda for the meeting includes the National Firefighter Registry for Cancer project overview, status, national launch updates, communication strategies, targeted enrollment approach, data review, and future planning applicable to stakeholders. Agenda items are subject to change as priorities dictate. The agenda is also posted on the NIOSH website at https://www.cdc.gov/ niosh/scientific-counselors/nfrs.html. Written Public Comment: Written comments will be accepted per the instructions provided in the addresses section above. Comments received in advance of the meeting are part of the public record and are subject to public disclosure. The comments will be included in the official record of the meeting. Do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. CDC will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/ near-duplicate examples of a mass-mail campaign. CDC will carefully consider all comments submitted into the docket. Frm 00052 Fmt 4703 Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–15794 Filed 7–17–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Public Participation PO 00000 Written comments received by August 15, 2024, will be provided to the Subcommittee prior to the meeting. Oral Public Comment: The public is welcome to participate during the public comment period, from 11:45 a.m. to 12 p.m., EDT, August 22, 2024. Each commenter will be provided up to five minutes for comment. A limited number of time slots are available and will be assigned on a first-come, first-served basis. Members of the public who wish to address the Subcommittee are requested to contact the Designated Federal Officer for scheduling purposes (see FOR FUTHER INFORMATION CONTACT above). The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sfmt 4703 Solicitation of Nominations for Appointment to the Advisory Committee on Immunization Practices Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS) is seeking nominations for membership on the Advisory Committee on Immunization Practices (ACIP). The ACIP consists of up to 19 experts in fields associated with immunization practices and public health, use of vaccines and other immunobiological agents in clinical practice or preventive medicine, clinical or laboratory vaccine research, assessment of vaccine efficacy and safety, or have knowledge about SUMMARY: E:\FR\FM\18JYN1.SGM 18JYN1 khammond on DSKJM1Z7X2PROD with NOTICES Federal Register / Vol. 89, No. 138 / Thursday, July 18, 2024 / Notices consumer perspectives and/or social and community aspects of immunization programs. DATES: Nominations for membership on the ACIP must be received no later than August 15, 2024. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations must be completed online at https:// www.cdc.gov/vaccines/acip/apply-formembership/. FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management Specialist, Advisory Committee on Immunization Practices, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24–8, Atlanta, Georgia 30329–4027. Telephone: (404) 639–8836; Email: ACIP@cdc.gov. SUPPLEMENTARY INFORMATION: The Advisory Committee on Immunization Practices (ACIP) is charged with advising the Director, Centers for Disease Control and Prevention (CDC), on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under applicable provisions of the Affordable Care Act and section 2713 of the Public Health Service Act and implementing regulations, immunization recommendations of ACIP that have been approved by the Director, CDC, and appear on CDC immunization schedules generally must be covered by applicable health plans. Nominations are being sought for individuals who have the expertise and qualifications necessary to contribute to the accomplishments of the committee’s objectives. Nominees will be selected based on expertise in the fields of immunization practices, multidisciplinary expertise in public health, expertise in the use of vaccines and immunologic agents in both clinical and preventive medicine, knowledge of vaccine development, evaluation, and vaccine delivery, or knowledge about consumer perspectives and/or social and community aspects of immunization programs. Federal employees will not be considered for membership. Members may be invited to serve for up to four-year terms. Selection of members is based on VerDate Sep<11>2014 16:47 Jul 17, 2024 Jkt 262001 candidates’ qualifications to contribute to the accomplishment of ACIP objectives (https://www.cdc.gov/ vaccines/acip/). HHS policy stipulates that committee membership be balanced in terms of points of view represented, and the committee’s function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens and cannot be full-time employees of the U.S. Government. Current participation on Federal workgroups or prior experience serving on a Federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Committee members are Special Government Employees, requiring the filing of financial disclosure reports at the beginning and annually during their terms. CDC reviews potential candidates for ACIP membership each year and provides a slate of nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected candidates of their appointment near the start of the term in July 2025, or as soon as the HHS selection process is completed. Note that the need for different expertise varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year. SGE nominees must be U.S. citizens and cannot be full-time employees of the U.S. Government. Candidates should submit the following items: ■ Current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address) ■ Two letters of recommendation from professional colleagues familiar with the candidate’s work. A maximum of four letters of recommendation will be accepted. Æ Letters of recommendation should not come from current ACIP members. Æ At least one letter of recommendation from person(s) not employed by HHS. Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency (e.g., National Institutes of Health, Food and Drug Administration, Substance Abuse and Mental Health Services Administration, etc.). CDC employees should not provide letters of recommendation. PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 58379 ■ A cover letter that includes the candidate’s statement of interest in serving on the ACIP, the qualifications and expertise that the candidate would bring, and written evidence to support how the candidate meets all relevant criteria. Nominations may be submitted by the candidate or by the person/organization recommending the candidate. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–15792 Filed 7–17–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Meeting of the Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board). This is a virtual meeting. It is open to the public, with a public comment period. The public is also welcome to submit written comments in advance of the meeting, to the contact person listed in the addresses section below. The public is also welcome to listen to the meeting by joining the teleconference (information below), limited only by the number of audio conference lines available (150). DATES: The meeting will be held on August 7, 2024, from 11 a.m. to 6 p.m., EDT, and on August 8, 2024, from 11 a.m. to 1 p.m., EDT. A public comment session will be held on August 7, 2024, SUMMARY: E:\FR\FM\18JYN1.SGM 18JYN1

Agencies

[Federal Register Volume 89, Number 138 (Thursday, July 18, 2024)]
[Notices]
[Pages 58378-58379]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15792]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the Advisory 
Committee on Immunization Practices

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), within the Department 
of Health and Human Services (HHS) is seeking nominations for 
membership on the Advisory Committee on Immunization Practices (ACIP). 
The ACIP consists of up to 19 experts in fields associated with 
immunization practices and public health, use of vaccines and other 
immunobiological agents in clinical practice or preventive medicine, 
clinical or laboratory vaccine research, assessment of vaccine efficacy 
and safety, or have knowledge about

[[Page 58379]]

consumer perspectives and/or social and community aspects of 
immunization programs.

DATES: Nominations for membership on the ACIP must be received no later 
than August 15, 2024. Packages received after this time will not be 
considered for the current membership cycle.

ADDRESSES: All nominations must be completed online at https://www.cdc.gov/vaccines/acip/apply-for-membership/.

FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management 
Specialist, Advisory Committee on Immunization Practices, National 
Center for Immunization and Respiratory Diseases, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta, 
Georgia 30329-4027. Telephone: (404) 639-8836; Email: [email protected].

SUPPLEMENTARY INFORMATION: The Advisory Committee on Immunization 
Practices (ACIP) is charged with advising the Director, Centers for 
Disease Control and Prevention (CDC), on the use of immunizing agents. 
In addition, under 42 U.S.C. 1396s, the Committee is mandated to 
establish and periodically review and, as appropriate, revise the list 
of vaccines for administration to vaccine-eligible children through the 
Vaccines for Children program, along with schedules regarding dosing 
interval, dosage, and contraindications to administration of vaccines. 
Further, under applicable provisions of the Affordable Care Act and 
section 2713 of the Public Health Service Act and implementing 
regulations, immunization recommendations of ACIP that have been 
approved by the Director, CDC, and appear on CDC immunization schedules 
generally must be covered by applicable health plans.
    Nominations are being sought for individuals who have the expertise 
and qualifications necessary to contribute to the accomplishments of 
the committee's objectives. Nominees will be selected based on 
expertise in the fields of immunization practices, multi-disciplinary 
expertise in public health, expertise in the use of vaccines and 
immunologic agents in both clinical and preventive medicine, knowledge 
of vaccine development, evaluation, and vaccine delivery, or knowledge 
about consumer perspectives and/or social and community aspects of 
immunization programs. Federal employees will not be considered for 
membership. Members may be invited to serve for up to four-year terms. 
Selection of members is based on candidates' qualifications to 
contribute to the accomplishment of ACIP objectives (https://www.cdc.gov/vaccines/acip/).
    HHS policy stipulates that committee membership be balanced in 
terms of points of view represented, and the committee's function. 
Appointments shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, gender identity, HIV 
status, disability, and cultural, religious, or socioeconomic status. 
Nominees must be U.S. citizens and cannot be full-time employees of the 
U.S. Government. Current participation on Federal workgroups or prior 
experience serving on a Federal advisory committee does not disqualify 
a candidate; however, HHS policy is to avoid excessive individual 
service on advisory committees and multiple committee memberships. 
Committee members are Special Government Employees, requiring the 
filing of financial disclosure reports at the beginning and annually 
during their terms. CDC reviews potential candidates for ACIP 
membership each year and provides a slate of nominees for consideration 
to the Secretary of HHS for final selection. HHS notifies selected 
candidates of their appointment near the start of the term in July 
2025, or as soon as the HHS selection process is completed. Note that 
the need for different expertise varies from year to year and a 
candidate who is not selected in one year may be reconsidered in a 
subsequent year. SGE nominees must be U.S. citizens and cannot be full-
time employees of the U.S. Government. Candidates should submit the 
following items:
    [squf] Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address)
    [squf] Two letters of recommendation from professional colleagues 
familiar with the candidate's work. A maximum of four letters of 
recommendation will be accepted.
    [cir] Letters of recommendation should not come from current ACIP 
members.
    [cir] At least one letter of recommendation from person(s) not 
employed by HHS. Candidates may submit letter(s) from current HHS 
employees if they wish, but at least one letter must be submitted by a 
person not employed by an HHS agency (e.g., National Institutes of 
Health, Food and Drug Administration, Substance Abuse and Mental Health 
Services Administration, etc.). CDC employees should not provide 
letters of recommendation.
    [squf] A cover letter that includes the candidate's statement of 
interest in serving on the ACIP, the qualifications and expertise that 
the candidate would bring, and written evidence to support how the 
candidate meets all relevant criteria.
    Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-15792 Filed 7-17-24; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.